InsidersTradesSigma
Track the 삼익제약 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 삼익제약 has published 5 insider filings. Market capitalisation: €41.1bn. The latest transaction was filed on 25 June 2026 (Sale). Among the most active insiders: 권영이. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
€76,464
1 ops.
Buy Volume
€89,675
4 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,247 of 29,063 companies
33.3
score / 100
Value21
Quality46
FCF yld-2.2%
Earn yld-1.2%
EV/EBITDA45.3x
ROE-1.2%
Gross mgn71%
Net mgn-1.3%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 June 2026
Declarations5 total
5 of 5 declarations
Acerca de 삼익제약
Samik Pharmaceutical es una empresa del sector de la salud y farmacéutico, que cotiza en la bolsa XKRX. Se centra en el desarrollo y la producción de medicamentos y productos farmacéuticos.